ARTICLE | Clinical News
Topamax topiramate regulatory update
November 11, 2002 8:00 AM UTC
JNJ submitted an sNDA to the FDA for Topamax as a monotherapy to treat epilepsy. Topamax is approved outside the U.S. as monotherapy, and in the U.S. for use in combination with other anti-epileptic m...